These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22843432)

  • 1. MicroRNA-125b-1 accelerates a C-terminal mutant of C/EBPα (C/EBPα-C(m))-induced myeloid leukemia.
    Enomoto Y; Kitaura J; Shimanuki M; Kato N; Nishimura K; Takahashi M; Nakakuma H; Kitamura T; Sonoki T
    Int J Hematol; 2012 Sep; 96(3):334-41. PubMed ID: 22843432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A.
    Chaudhuri AA; So AY; Mehta A; Minisandram A; Sinha N; Jonsson VD; Rao DS; O'Connell RM; Baltimore D
    Proc Natl Acad Sci U S A; 2012 Mar; 109(11):4233-8. PubMed ID: 22366319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA miR-125b causes leukemia.
    Bousquet M; Harris MH; Zhou B; Lodish HF
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21558-63. PubMed ID: 21118985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A C-terminal mutant of CCAAT-enhancer-binding protein α (C/EBPα-Cm) downregulates Csf1r, a potent accelerator in the progression of acute myeloid leukemia with C/EBPα-Cm.
    Togami K; Kitaura J; Uchida T; Inoue D; Nishimura K; Kawabata KC; Nagase R; Horikawa S; Izawa K; Fukuyama T; Nakahara F; Oki T; Harada Y; Harada H; Aburatani H; Kitamura T
    Exp Hematol; 2015 Apr; 43(4):300-8.e1. PubMed ID: 25534203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancy.
    Wagner K; Zhang P; Rosenbauer F; Drescher B; Kobayashi S; Radomska HS; Kutok JL; Gilliland DG; Krauter J; Tenen DG
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6338-43. PubMed ID: 16606850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-125b transforms myeloid cell lines by repressing multiple mRNA.
    Bousquet M; Nguyen D; Chen C; Shields L; Lodish HF
    Haematologica; 2012 Nov; 97(11):1713-21. PubMed ID: 22689670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two types of C/EBPα mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models.
    Kato N; Kitaura J; Doki N; Komeno Y; Watanabe-Okochi N; Togami K; Nakahara F; Oki T; Enomoto Y; Fukuchi Y; Nakajima H; Harada Y; Harada H; Kitamura T
    Blood; 2011 Jan; 117(1):221-33. PubMed ID: 20884804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eμ/miR-125b transgenic mice develop lethal B-cell malignancies.
    Enomoto Y; Kitaura J; Hatakeyama K; Watanuki J; Akasaka T; Kato N; Shimanuki M; Nishimura K; Takahashi M; Taniwaki M; Haferlach C; Siebert R; Dyer MJ; Asou N; Aburatani H; Nakakuma H; Kitamura T; Sonoki T
    Leukemia; 2011 Dec; 25(12):1849-56. PubMed ID: 21738213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
    Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
    Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.
    Asou H; Gombart AF; Takeuchi S; Tanaka H; Tanioka M; Matsui H; Kimura A; Inaba T; Koeffler HP
    Genes Chromosomes Cancer; 2003 Feb; 36(2):167-74. PubMed ID: 12508245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CCL9/MIP-1gamma is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells.
    Iotti G; Ferrari-Amorotti G; Rosafio C; Corradini F; Lidonnici MR; Ronchetti M; Bardini M; Zhang Y; Martinez R; Blasi F; Calabretta B
    Oncogene; 2007 May; 26(24):3482-91. PubMed ID: 17160016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual mechanisms by which miR-125b represses IRF4 to induce myeloid and B-cell leukemias.
    So AY; Sookram R; Chaudhuri AA; Minisandram A; Cheng D; Xie C; Lim EL; Flores YG; Jiang S; Kim JT; Keown C; Ramakrishnan P; Baltimore D
    Blood; 2014 Aug; 124(9):1502-12. PubMed ID: 25006123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The deregulated expression of miR-125b in acute myeloid leukemia is dependent on the transcription factor C/EBPα.
    Vargas Romero P; Cialfi S; Palermo R; De Blasio C; Checquolo S; Bellavia D; Chiaretti S; Foà R; Amadori A; Gulino A; Zardo G; Talora C; Screpanti I
    Leukemia; 2015 Dec; 29(12):2442-5. PubMed ID: 25982911
    [No Abstract]   [Full Text] [Related]  

  • 14. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.
    Perrotti D; Cesi V; Trotta R; Guerzoni C; Santilli G; Campbell K; Iervolino A; Condorelli F; Gambacorti-Passerini C; Caligiuri MA; Calabretta B
    Nat Genet; 2002 Jan; 30(1):48-58. PubMed ID: 11753385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of microRNA-125b inhibits human acute myeloid leukemia cells invasion, proliferation and promotes cells apoptosis by targeting NF-κB signaling pathway.
    Wang Y; Tang P; Chen Y; Chen J; Ma R; Sun L
    Biochem Biophys Res Commun; 2017 Jun; 488(1):60-66. PubMed ID: 28478034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reintroduction of C/EBPalpha in leukemic CD34+ stem/progenitor cells impairs self-renewal and partially restores myelopoiesis.
    Schepers H; Wierenga AT; van Gosliga D; Eggen BJ; Vellenga E; Schuringa JJ
    Blood; 2007 Aug; 110(4):1317-25. PubMed ID: 17475913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
    Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
    Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia.
    Hughes JM; Legnini I; Salvatori B; Masciarelli S; Marchioni M; Fazi F; Morlando M; Bozzoni I; Fatica A
    Oncotarget; 2015 Jul; 6(21):18534-44. PubMed ID: 26053097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C/EBPβ promotes BCR-ABL-mediated myeloid expansion and leukemic stem cell exhaustion.
    Hayashi Y; Hirai H; Kamio N; Yao H; Yoshioka S; Miura Y; Ashihara E; Fujiyama Y; Tenen DG; Maekawa T
    Leukemia; 2013 Mar; 27(3):619-28. PubMed ID: 22948537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia.
    Klusmann JH; Li Z; Böhmer K; Maroz A; Koch ML; Emmrich S; Godinho FJ; Orkin SH; Reinhardt D
    Genes Dev; 2010 Mar; 24(5):478-90. PubMed ID: 20194440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.